Hauso O, Gustafsson BI, Kidd M, et al. Neuroendocrine tumor epidemiology: contrasting Norway and North America. Cancer. 2008;113:2655–64.
Yao JC, Hassan M, Phan A, et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26:3063–72.
Obernforfer S. Karzinoide tumoren desn dunndarms. Frankfurt Z Path. 1907;1:426–32.
Capella C, Heitz PU, Höfler H, Solcia E, Klöppel G. Revised classification of neuroendocrine tumours of the lung, pancreas and gut. Virchows Arch. 1995;425:547–60.
Article CAS PubMed Google Scholar
Japanese Neuroendocrine Tumors Society (JNETS). Clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN). Kanehara Inc.; 2019. p. 103–4.
Rindi G, Luinetti O, Cornaggia M, et al. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study. Gastroenterology. 1993;104:994–1006.
Article CAS PubMed Google Scholar
Modlin IM, Kidd M, Latich I, et al. Current status of gastrointestinal carcinoids. Gastroenterology. 2005;128:1717–51.
Panzuto F, Campana D, Massironi S, et al. Tumour type and size are prognostic factors in gastric neuroendocrine neoplasia: a multicentre retrospective study. Dig Liver Dis. 2019;51:1456–60.
Delle Fave G, O’Toole D, Sundin A, et al. Vienna consensus conference participants. ENETS consensus guidelines update for gastroduodenal neuroendocrine neoplasms. Neuroendocrinology. 2016;103:119–24.
Article CAS PubMed Google Scholar
Janson ET, Knigge U, Dam G, Federspiel B, Grønbaek H, Stålberg P, Langer SW, Kjaer A, Arola J, Schalin-Jäntti C, Sundin A, Welin S, Thiis-Evensen E, Sorbye H. Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms. Acta Oncol. 2021;60:931–41.
Deprez PH, Moons LMG, Oʼ Toole D, et al. Endoscopic management of subepithelial lesions including neuroendocrine neoplasms: European society of gastrointestinal endoscopy (ESGE) guideline. Endoscopy. 2022;54:412–29.
Panzuto F, Ramage J, Pritchard DM, et al. European neuroendocrine tumor society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1–G3. J Neuroendocrinol. 2023;35: e13306.
Article CAS PubMed Google Scholar
Faulx AL, Kothari S, Acosta RD, Standards of Practice Committee, et al. The role of endoscopy in subepithelial lesions of the GI tract. Gastrointest Endosc. 2017;85:1117–32.
Rindi G, Bordi C, Rappel S, et al. Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior. World J Surg. 1996;20:168–72.
Article CAS PubMed Google Scholar
Basuroy R, Srirajaskanthan R, Prachalias A, et al. Review article: the investigation and management of gastric neuroendocrine tumours. Aliment Pharmacol Ther. 2014;39:1071–84.
Article CAS PubMed Google Scholar
Domori K, Nishikura K, Ajioka Y, et al. Mucin phenotype expression of gastric neuroendocrine neoplasms: analysis of histopathology and carcinogenesis. Gastric Cancer. 2014;17:263–72.
Article CAS PubMed Google Scholar
Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd english edition. Gastric Cancer. 2011;14:101–12.
Rindi G, Klöppel G, Alhman H, et al. All other frascati consensus conference participants; European neuroendocrine tumor society (ENETS) TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 2006;449:395–401.
Article CAS PubMed PubMed Central Google Scholar
Rindi G, Arnold R, Bosman FT, et al. WHO classification of tumours of the digestive system. 4th ed. Lyon: IARC Press; 2010. p. 13–4.
Köseoğlu H, Duzenli T, Sezikli M. Gastric neuroendocrine neoplasms: a review. World J Clin Cases. 2021;9:7973–85.
Article PubMed PubMed Central Google Scholar
Modlin IM, Zucker KA, Zdon MJ, et al. Characteristics of the spontaneous gastric endocrine tumor of mastomys. J Surg Res. 1988;44:205–15.
Article CAS PubMed Google Scholar
Bilchik AJ, Nilsson O, Modlin IM, et al. H2-receptor blockade induces peptide YY and enteroglucagon-secreting gastric carcinoids in mastomys. Surgery. 1989;106:1119–26.
Modlin IM, Nangia AK. The pathobiology of the human enterochromaffin-like cell. Yale J Biol Med. 1992;65:775–92.
CAS PubMed PubMed Central Google Scholar
Kwon YH, Jeon SW, Kim GH, et al. Long-term follow up of endoscopic resection for type 3 gastric NET. World J Gastroenterol. 2013;19:8703–8.
Article PubMed PubMed Central Google Scholar
Min BH, Hong M, Lee JH, et al. Clinicopathological features and outcome of type 3 gastric neuroendocrine tumours. Br J Surg. 2018;105:1480–6.
Lahner E, Pilozzi E, Esposito G, et al. Gastric carcinoid in the absence of atrophic body gastritis and with low Ki67 index: a clinical challenge. Scand J Gastroenterol. 2014;49:506–10.
Scherübl H, Cadiot G, Jensen RT, et al. Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: small tumors, small problems? Endoscopy. 2010;42:664–71.
Singh R, Yao K, Anagnostopoulos G, et al. Microcarcinoid tumor diagnosed with high-resolution magnification endoscopy and narrow band imaging. Endoscopy. 2008;40(Suppl 2):E12.
Hirai M, Matsumoto K, Ueyama H, et al. A case of neuroendocrine tumor G1 with unique histopathological growth progress. World J Gastrointest Endosc. 2013;5:605–9.
Article PubMed PubMed Central Google Scholar
Rappel S, Altendorf-Hofmann A, Stolte M. Prognosis of gastric carcinoid tumours. Digestion. 1995;56:455–62.
Article CAS PubMed Google Scholar
Kunz PL, Reidy-Lagunes D, Anthony LB, et al. North American neuroendocrine tumor society consensus guidelines for the management and treatment of neuroendocrine tumors. Pancreas. 2013;42:557–77.
留言 (0)